76 related articles for article (PubMed ID: 19564161)
21. Heart-type fatty acid binding protein is a novel prognostic marker in patients with non-ischaemic dilated cardiomyopathy.
Komamura K; Sasaki T; Hanatani A; Kim J; Hashimura K; Ishida Y; Ohkaru Y; Asayama K; Tanaka T; Ogai A; Nakatani T; Kitamura S; Kangawa K; Miyatake K; Kitakaze M
Heart; 2006 May; 92(5):615-8. PubMed ID: 16387818
[TBL] [Abstract][Full Text] [Related]
22. A superior early myocardial infarction marker. Human heart-type fatty acid-binding protein.
Chan CP; Sanderson JE; Glatz JF; Cheng WS; Hempel A; Renneberg R
Z Kardiol; 2004 May; 93(5):388-97. PubMed ID: 15160274
[TBL] [Abstract][Full Text] [Related]
23. Liver-type fatty acid binding protein in serum and broncho-alveolar lavage in a model of acute respiratory failure because of surfactant depletion--a possible marker for lung damage?
Lachmann RA; Werchan S; Schachtrup C; Haitsma JJ; Spener F; Lachmann B
Clin Physiol Funct Imaging; 2006 Nov; 26(6):371-5. PubMed ID: 17042904
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain.
McCann CJ; Glover BM; Menown IB; Moore MJ; McEneny J; Owens CG; Smith B; Sharpe PC; Young IS; Adgey JA
Am J Cardiol; 2009 Jan; 103(1):22-8. PubMed ID: 19101224
[TBL] [Abstract][Full Text] [Related]
25. Performance of a semi-quantitative whole blood test for human heart-type fatty acid-binding protein (H-FABP).
Hiura M; Nakajima O; Mori T; Kitano K
Clin Biochem; 2005 Oct; 38(10):948-50. PubMed ID: 16051209
[TBL] [Abstract][Full Text] [Related]
26. Treatment with atorvastatin reduces serum adipocyte-fatty acid binding protein value in patients with hyperlipidaemia.
Karpisek M; Stejskal D; Kotolova H; Kollar P; Janoutova G; Ochmanova R; Cizek L; Horakova D; Yahia RB; Lichnovska R; Janout V
Eur J Clin Invest; 2007 Aug; 37(8):637-42. PubMed ID: 17635574
[TBL] [Abstract][Full Text] [Related]
27. Verification of an immunoturbidimetric assay for heart-type fatty acid-binding protein (H-FABP) on a clinical chemistry platform and establishment of the upper reference limit.
Da Molin S; Cappellini F; Falbo R; Signorini S; Brambilla P
Clin Biochem; 2014 Nov; 47(16-17):247-9. PubMed ID: 25046653
[TBL] [Abstract][Full Text] [Related]
28. Serum heart-type fatty acid binding protein predicts cardiac events in elderly patients with chronic heart failure.
Niizeki T; Takeishi Y; Arimoto T; Okuyama H; Takabatake N; Tachibana H; Nozaki N; Hirono O; Tsunoda Y; Miyashita T; Fukui A; Takahashi H; Koyama Y; Shishido T; Kubota I
J Cardiol; 2005 Jul; 46(1):9-15. PubMed ID: 16095226
[TBL] [Abstract][Full Text] [Related]
29. [Diagnostic and prognostic value of heart-type fatty acid-binding protein (H-FABP), an early biochemical marker of myocardial injury].
Bertinchant JP; Polge A
Arch Mal Coeur Vaiss; 2005 Dec; 98(12):1225-31. PubMed ID: 16435602
[TBL] [Abstract][Full Text] [Related]
30. Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort.
Tso AW; Xu A; Sham PC; Wat NM; Wang Y; Fong CH; Cheung BM; Janus ED; Lam KS
Diabetes Care; 2007 Oct; 30(10):2667-72. PubMed ID: 17620449
[TBL] [Abstract][Full Text] [Related]
31. Estimation of glomerular filtration rate: does haemoglobin discriminate between ageing and true CKD?
Ferrari P; Xiao J; Ukich A; Irish A
Nephrol Dial Transplant; 2009 Jun; 24(6):1828-33. PubMed ID: 19131346
[TBL] [Abstract][Full Text] [Related]
32. Establishment and characterization of monoclonal and polyclonal antibodies against human intestinal fatty acid-binding protein (I-FABP) using synthetic regional peptides and recombinant I-FABP.
Kajiura S; Yashiki T; Funaoka H; Ohkaru Y; Nishikura K; Kanda T; Ajioka Y; Igarashi M; Hatakeyama K; Fujii H
J Immunoassay Immunochem; 2008; 29(1):19-41. PubMed ID: 18080878
[TBL] [Abstract][Full Text] [Related]
33. [Multicenter evaluation of h-FABP semi-quantitative assay (Cardio Detect) in central laboratory: the point in acute myocardial infarction diagnosis].
Lefèvre G; Fayet JM; Graïne H; Berny C; Maupas-Schwalm F; Capolaghi B; Morin C
Ann Biol Clin (Paris); 2007; 65(4):377-84. PubMed ID: 17627918
[TBL] [Abstract][Full Text] [Related]
34. Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism.
Puls M; Dellas C; Lankeit M; Olschewski M; Binder L; Geibel A; Reiner C; Schäfer K; Hasenfuss G; Konstantinides S
Eur Heart J; 2007 Jan; 28(2):224-9. PubMed ID: 17127709
[TBL] [Abstract][Full Text] [Related]
35. Fatty acid-binding proteins as plasma markers of tissue injury.
Pelsers MM; Hermens WT; Glatz JF
Clin Chim Acta; 2005 Feb; 352(1-2):15-35. PubMed ID: 15653098
[TBL] [Abstract][Full Text] [Related]
36. Relationship between arterial stiffness and myocardial damage in patients with newly diagnosed essential hypertension.
Gedikli O; Ozturk S; Yilmaz H; Baykan M; Kiris A; Durmus I; Baltaci D; Karahan C; Celik S
Am J Hypertens; 2008 Sep; 21(9):989-93. PubMed ID: 18617881
[TBL] [Abstract][Full Text] [Related]
37. Heart-type fatty acid-binding protein is a useful marker for organ dysfunction and leptin alleviates sepsis-induced organ injuries by restraining its tissue levels.
Yan GT; Lin J; Hao XH; Xue H; Zhang K; Wang LH
Eur J Pharmacol; 2009 Aug; 616(1-3):244-50. PubMed ID: 19576209
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of a heart-type fatty acid-binding protein (H-FABP) bedside test in suspected acute coronary syndrome in primary care.
Bruins Slot MH; Rutten FH; van der Heijden GJ; Doevendans PA; Mast EG; Bredero AC; van der Spoel OP; Glatz JF; Hoes AW
Int J Cardiol; 2013 Sep; 168(2):1485-9. PubMed ID: 23332896
[TBL] [Abstract][Full Text] [Related]
39. Urinary excretion of liver-type fatty acid-binding protein as a marker of progressive kidney function deterioration in patients with chronic glomerulonephritis.
Mou S; Wang Q; Li J; Shi B; Ni Z
Clin Chim Acta; 2012 Jan; 413(1-2):187-91. PubMed ID: 21958699
[TBL] [Abstract][Full Text] [Related]
40. Development of a high-specificity sandwich ELISA system for the quantification of human intestinal fatty acid-binding protein (I-FABP) concentrations.
Funaoka H; Kanda T; Kajiura S; Ohkaru Y; Fujii H
Immunol Invest; 2011; 40(3):223-42. PubMed ID: 21204605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
